About
our team
alt
Richard A. Brown

Partner & Head, Tokyo Office

Tokyo
+81-(0)50-5806-8475

richard_brown@plexusventures.com

Richard Brown, a U.S. national, joined Plexus Ventures in 2006 following 26 years at Eli Lilly and Company, where he held positions in Business Development, Marketing and General Management.

Rich Brown’s most recent position at Eli Lilly and Company was in Business Development with responsibility for Japan and West Coast US biotech collaborations. Announced in July 2005, Lilly’s in-license of Taisho Pharmaceutical’s DPPIV inhibitor in Phase 1 was negotiated by Rich.

Mr. Brown has held management roles in marketing capabilities assessment, customer relationship management and business development. Mr. Brown was transferred to Kobe, Japan in 1991 to head up Lilly-Japan’s nascent market research and new product planning group. Returning in 1994 to direct Lilly’s US contract pricing group, Rich was again sent abroad to Moscow as managing director of Lilly-CIS. Rich holds an MBA from Harvard Business School.

Rich Brown’s hands-on experience in the USA, Japanese and Russian pharmaceutical markets has allowed him to apply a variety of successful strategies and to obtain insight into the differential drivers of success in each market.